Open AccessP497: PROGNOSTIC IMPACT OF RAS AND C‐KIT MUTATIONS (SINGLE VS. MULTIPLE) IN CORE‐BINDING FACTOR ACUTE MYELOID LEUKEMIA TREATED WITH FLUDARABINE, CYTARABINE, G‐CSF (FLAG) BASED REGIMEN
Author(s) -
Abuasab T.,
Senapati J.,
Kadia T.,
Ravandi F.,
DiNardo C.,
Pemmaraju N.,
Ohanion M.,
Alvarado Y.,
Kantarjian H.,
Borthakur G.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844876.07918.0f
Subject(s) - fludarabine , cytarabine , idarubicin , medicine , gemtuzumab ozogamicin , oncology , myeloid leukemia , npm1 , regimen , immunology , chemotherapy , cd33 , biology , cyclophosphamide , genetics , gene , cd34 , stem cell , karyotype , chromosome